AVTX Avalo Therapeutics
- 7.0000
- -2.0500-22.65%
- 7.8200
- +0.8200+11.71%
Avalo Therapeutics News
Avalo Therapeutics | 8-K: Current report
Avalo Therapeutics | 8-K: Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
Avalo Therapeutics | 8-K: Current report
Avalo Therapeutics | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Avalo Therapeutics | 8-K: Current report
Avalo Therapeutics | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Avalo Therapeutics | 8-K: Current report
Avalo Therapeutics | DEFA14A: Others
Avalo Therapeutics | DEF 14A: Definitive information statements
Avalo Therapeutics | 8-K: Current report
Avalo Therapeutics | 8-K/A: Current report (Amendment)
Avalo Therapeutics | 8-K: Current report
Avalo Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Avalo Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Avalo Therapeutics | 8-K/A: Current report (Amendment)
Avalo Therapeutics | 8-K: Current report
Avalo Therapeutics | 8-K: Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
Avalo Therapeutics | 8-K: Current report
Avalo Therapeutics | DEFA14A: Others
Avalo Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
